CHARNEAU PIERRE has a total of 13 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are THERAVECTYS, PANTHECO AS and DNAVEC RESEARCH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Agriculture | |
#5 | Measurement | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Animal care | |
#7 | Analysing materials | |
#8 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Charneau Pierre | 13 |
#2 | Zennou Veronique | 6 |
#3 | Coutant Frederic Philippe | 4 |
#4 | Sirven Aride | 3 |
#5 | Dubart Anne | 3 |
#6 | Pflumio Francoise | 3 |
#7 | Despres Philippe | 2 |
#8 | Firat Hueseyin | 2 |
#9 | Courbeyrette Karine | 2 |
#10 | Beignon Anne-Sophie | 2 |
Publication | Filing date | Title |
---|---|---|
US2010028382A1 | Lentiviral vector-based vaccine | |
US2007087354A1 | Lentiviral vector-based vaccine |